(Reuters) - Medtronic Inc said it agreed to pay $85 million to settle a shareholder lawsuit accusing it of making misleading statements concerning Infuse, a genetically engineered bone graft used in spinal surgery.
radon engineering remote application monitoring british business gas
No comments:
Post a Comment